Materials • Major Chemicals
$3.33 ▲ +0.16
(+5.05%)
MKT CAP: $669.0M • VOL: 8.26M
52W L $3 52W H $14
PCT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.4M | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$181.4M | -$145.4M | -$113.9M |
| Operating Margin % | -80.0% | — | — |
| Net Income (GAAP) | -$182.6M | -$289.1M | -$101.7M |
| EBITDA (Normalized) | -$148.8M | -$100.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$142.7M | -$144.8M | -$94.9M |
| Capital Expenditures (CapEx) | $40.8M | $55.6M | — |
| Free Cash Flow (FCF) | -$183.6M | -$200.4M | -$94.9M |
| FCF Margin % | -80.0% | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $156.7M | $15.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $45.9M | $180.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PCT.